Physician profile
Stephen D Rice
NPI 1144228495
$2,846.24
in general payments reported to CMS, 2019-2025
9 companies · $1,211 in 2025
The $1,211 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $70.81 · 2021: $24.75 · 2022: $516 · 2023: $303 · 2024: $721 · 2025: $1,211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,627 · Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,626.53 |
| Food and Beverage | $608.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,330.32 | 2020-2025 | Glidesheath Slender, Azur Cx Detachable, Hydropearl |
| Medtronic, INC. | $1,052.86 | 2021-2025 | Valiant Captivia, Endurant Iis, In.Pact Admiral |
| Ge Healthcare | $117.41 | 2022 | |
| Philips North America LLC | $96.27 | 2022 | |
| Penumbra, INC. | $90.75 | 2022 | |
| Abbott Laboratories | $55.89 | 2023 | Diamondback Peripheral |
| Medtronic Vascular, INC. | $54.53 | 2020 | |
| Geron Corporation | $27.51 | 2024 | Rytelo |
| Cardiovascular Systems INC. | $20.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.